Aida Kuzucan

United States Food and Drug Administration

Also affiliated with Center for Drug Evaluation and Research

Economics, Econometrics and FinanceImmunology and MicrobiologyComputer ScienceDecision Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHD”.

FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHD

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0688

N/A

0.208DataRank · unranked

3 citations

Donna R. Rivera, Joseph Wynne, Jian Zhao, Robyn Konicki, Aida Kuzucan +8 more

Real‐World Evidence in New Drug and Biologics License Application Approvals During Fiscal Years 2020–2022

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3688

N/A

0DataRank · unranked

6 citations

Kimberly Smith, Aida Kuzucan, Jie Li, Donna R. Rivera, Orestis A. Panagiotou +2 more